Table 1. Characteristics of GBM patients from whom neurospheres were derived.
| Groups | Patient | Sex | Age (years) | Therapy | Overall survival (months) | Status |
|---|---|---|---|---|---|---|
| X-1 | #1 (GSC-1) | M | 69 | RX+TMZ | 15 | Dead |
| #2 (GSC-2) | M | 57 | RX+TMZ | 9 | Dead | |
| #4 (GSC-4) | M | 50 | RX+TMZ | >18 | Alive | |
| #6 (GSC-6) | M | 53 | RX+TMZ | 10 | Dead | |
| #8 (GSC-8) | F | 54 | none | 2 | Dead | |
| #10 (GSC-10) | M | 69 | RX+TMZ | >18 | Alive | |
| X-2 | #3 (GSC-3) | M | 56 | RX+TMZ | 9 | Dead |
| #5 (GSC-5) | F | 65 | RX+TMZ | 13 | Dead | |
| #7 (GSC-7) | M | 51 | RX+TMZ | 13 | Dead | |
| #9 (GSC-9) | M | 56 | RX+TMZ | 6 | Dead | |
| #11 (GSC-11) | M | 61 | RX+TMZ | >18 | Alive |
Abbreviations: GBM, glioblastoma; GSC, glioma stem cell; RX, radiotherapy 60 Gy; TMZ, temozolomide.